![Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection](https://mma.prnewswire.com/media/1485582/Nasus_Pharma_Logo.jpg?p=twitter)
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
![Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel](https://static.timesofisrael.com/www/uploads/2021/02/taffix-640x400.jpg)
Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel
Low pH Hypromellose (Ta x™) nasal powder spray reduced SARS-CoV-2 infection rate post mass- gathering event at a highly endemi
Taffix™ is a scientifically proven nasal spray that creates a hostile microenvironment in the nose where up to 97% of airborne viruses can't survive.... | By PAC3 - Facebook
![Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel](https://static.timesofisrael.com/www/uploads/2021/02/taffixnose-1024x640.jpg)
Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel
![Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection Against SARS-CoV-2 in Super Spread Event Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection Against SARS-CoV-2 in Super Spread Event](https://mma.prnewswire.com/media/1311013/Nasus_Pharma_Logo.jpg?p=facebook)
Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection Against SARS-CoV-2 in Super Spread Event
![Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta) Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)](https://www.fortunejournals.com/fulltext-images/taffixreg-nasal-powder-spray-forms-03.png)
Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)
![Covid Spain: Regulators BAN £51 Taffix nasal spray that studies show may cut infection risk | Daily Mail Online Covid Spain: Regulators BAN £51 Taffix nasal spray that studies show may cut infection risk | Daily Mail Online](https://i.dailymail.co.uk/1s/2021/03/16/17/40548952-0-image-a-3_1615914265002.jpg)